Immunoprecipitation

The optimal immunoprecipitation reagent depends on your target protein, for example whether it is tagged or untagged and high- or low-abundance, as well as on the experimental conditions and downstream application.

Nano-Traps are recommended for the IP of tagged proteins (e.g., fluorescent protein tags like GFP-tag and RFP-tag, or peptide tags like Strep, His, V5, Myc, FLAG, etc.) and selected endogenous proteins (e.g., Ubiquitin, SUMO1, NEDD8, p53, PARP1, etc.), especially for low-abundance targets, applications requiring stringent lysis or washing conditions (e.g., ubiquitination assays, plant lysates, or IP-MS or AP-MS), or workflows where speed, sensitivity, and reproducibility are critical.

Anti-IgG VHH Beads offer a cleaner, more efficient alternative to conventional Protein A/G. Unlike Protein A/G, which binds IgGs from multiple species with varying affinities, anti-IgG VHH Beads are optimized for their respective species or isotype, resulting in higher specificity and reduced background. This is especially beneficial when working with serum samples or samples containing BSA, FCS, or HSA, such as commercial antibody formulations, since this can lead to substantial background when using Protein A/G (bovine or human IgG contamination).

While Protein A and G remain the most common choices for antibody capture, their broad and unspecific Fc binding and potential for leaching from beads can compromise specificity and lead to interfering background in sensitive assays. Our anti-IgG VHH Beads use secondary VHHs coupled to agarose or magnetic agarose beads and are optimized for targeted precision and clean results.

Nano-Traps use primary VHHs coupled to magnetic or agarose beads and are the preferred choice for immunoprecipitation of proteins that carry an affinity tag such as GFP, Myc, HA, or V5. They are also available for a range of endogenous targets, including Ubiquitin, SUMO, NEDD8, and ISG15.

Compared to Protein A/G-based IPs, Nano-Trap-based IPs are cleaner and more efficient. Because Nano-Traps do not rely on antibodies for target capture, they eliminate heavy and light chain antibody contamination in downstream analysis such as Western blot or mass spectrometry. They also enable faster, one-step pulldowns that can be completed in under 2 hours, whereas Protein A/G protocols typically take at least 3 hours since they require an additional incubation step with the IgG or a pre-assembly of beads.

Background in immunoprecipitation experiments can occur due to degradation of the protein of interest, non-specific binding to the beads, or Protein A/G leaching from the beads and interfering with downstream Western blot detection.

To reduce background, we recommend:

1. Optimize lysate preparation for your specific cell type and use an appropriate amount of starting material. Too little material will result in low signals, while too much input material will increase the risk of background binding. Add sufficient protease inhibitors to minimize degradation of proteins. Depending on your research question, you may want to add specific inhibitors to counter, for example, dephosphorylation.
2. Optimize binding conditions by incubating at 4 °C for a maximum of 1 hour. Longer incubation times or higher temperatures will increase the risk of degrading your protein of interest or of precipitate formation, which will result in background binding.
3. Optimize washing conditions by increasing salt or detergent concentrations or frequency of washing. Increasing NaCl or KCl concentrations may help to reduce background in the case of DNA-binding proteins, for example. However, a careful approach is necessary, as overly stringent wash conditions may also inadvertently eliminate real interaction partners of your protein of interest. Use a fresh tube for the final wash step to reduce background from proteins sticking to plastic surfaces.
4. Include a pre-clearing step: Pre-clearing is not routinely needed for Nano-Traps but may be relevant for Protein A/G-based approaches. For example, samples such as serum may contain antibodies, which may compete with your primary antibody for Protein A/G binding. Reduce endogenous antibodies with Protein A/G-bead pre-clearing or use the appropriate anti-IgG VHH Beads to circumvent this problem. Samples may also contain antibody-binding proteins, which will lead to background binding, but can be eliminated using pre-clearing with an isotype control.

Tip: Unlike conventional Protein A/G-based approaches, nanobody-based reagents (Nano-Traps, anti-IgG VHH Beads) are designed for highly specific target binding, minimizing background and increasing consistency of your workflows.

ChromoTek nanobodies exhibit high binding affinities in the picomolar to nanomolar range and are highly target-specific. Their small size and compact structure contribute to their thermostability and robustness under stringent washing and lysis buffer conditions, including high salt, detergents, reducing agents, and chaotropic agents such as urea.

Since Nano-Traps rely exclusively on immobilized nanobodies and do not require a capture antibody, this format offers particular benefits for the pulldown of low-abundance targets, and for IPs under demanding conditions, where high affinity, specificity, and stability are key.

To avoid antibody heavy and light chain bands masking your protein of interest, we recommend the following strategies:

• Use different antibody species for capture and detection, so your Western blot secondary antibody does not bind to both.
• Use SpeedAb Kits: If switching species is not feasible, we recommend our SpeedAb Kits. They include FlexAble HRP, a solution to label primary antibodies with HRP. This enables 1-step detection without a secondary antibody and helps circumvent this problem. Note: SpeedAb kits additionally contain our Blotting Accelerator, a solution with special organic compounds that lets you skip the blocking step and speed up antibody incubation when antibodies are diluted in it.
• Use conformation-specific secondaries: Use a secondary antibody that only binds native, but not denatured IgG, such as the HRP-Goat anti-rabbit IgG conformation-specific recombinant secondary antibody.
• Cross-link your antibody: Covalently cross-link your IP antibody to the bead, so it does not elute with your sample.
• Avoid antibody contamination altogether: Our Nano-Traps rely on primary nanobodies that bind directly to their target without requiring a traditional capture antibody, entirely eliminating antibody contamination of your eluate.

As a starting point, we recommend using lysate from about 0.5–1 × 10⁶ cells per IP reaction for many mammalian cell lines, but the exact number strongly depends on the cell type, cell size, and the expression level of your protein of interest. For highly overexpressed tagged proteins, you can often use fewer cells, whereas for endogenous, low-abundance, or complex-associated targets, especially in Co-IPs, you may need substantially more material, up to the 10⁷-cell range. The optimal cell number should therefore always be determined empirically by a small titration series.

For the pulldown of membrane proteins, we recommend using mild nonionic or zwitterionic detergents for cell lysis. Optimize both the detergent concentration and salt conditions to ensure that your membrane protein is fully solubilized while preserving co-precipitation of known interaction partners. Our Lys-Buf provides a mild starting point for testing, whereas our RIPA buffer offers strong lysis but can disrupt weak or transient interactions can be stabilized before or during lysis using gentle crosslinkers or nanodisc/detergent‑free approaches.

A weak or missing signal after an IP typically indicates that the protein degraded, failed to bind the matrix, or is physically obscured on your blot. Troubleshoot your protocol using these tips:

• Include proper experimental controls: Always run an input control and a positive control to verify your target protein is present and your Western blot detection works.
• Ensure your capture antibody is validated for IP. The target epitope must be accessible on the 3D protein surface since the protein is in a native state.
• Check lysis buffer restrictions: Antibodies may lose function in lysates containing reducing agents, extreme pH, or high detergent concentrations.
• Optimize sample preparation: Prevent protein degradation by keeping lysates on ice and using fresh samples with protease inhibitors.
• Optimize wash stringency: If your target-protein interaction is fragile, reduce the number of washes or decrease the salt and detergent concentrations.
• Verify bead-antibody compatibility: Traditional Protein A or G beads have a weak affinity for certain antibody species and subclasses, risking that you lose your antibody during IP.

Protocols are available in the following places:

• Standard immunoprecipitation protocol.
• Nano-Trap and anti-IgG VHH Bead protocols are available on the product information section of each product page.
• On-bead digestion protocol for IP-MS and AP-MS workflows.